Mendelian randomisation studies of type 2 diabetes: future prospects M. S. SandhuS. L. DebenhamR. J. F. Loos Commentary 19 December 2007 Pages: 211 - 213
The mechanisms of alloxan- and streptozotocin-induced diabetes S. Lenzen Review 18 December 2007 Pages: 216 - 226
Optimising islet engraftment is critical for successful clinical islet transplantation O KorsgrenT LundgrenB Nilsson For Debate 27 November 2007 Pages: 227 - 232
Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis D. T. GolickiD. GolickaE. Pankowska Meta-analysis 01 December 2007 Pages: 233 - 240
Predictors of cognitive impairment and dementia in older people with diabetes D. G. BruceW. A. DavisT. M. E. Davis Article 05 December 2007 Pages: 241 - 248
Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark S. S. RasmussenC. GlümerK. Borch-Johnsen Article 05 December 2007 Pages: 249 - 257
Duration of breast-feeding and the incidence of type 2 diabetes mellitus in the Shanghai Women’s Health Study R. VillegasY.-T. GaoX.-O. Shu Article Open access 27 November 2007 Pages: 258 - 266
HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women E. B. LevitanS. LiuJ. E. Manson Article 28 November 2007 Pages: 267 - 275
Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002 C. HerderN. KloppB. Thorand Article 22 August 2007 Pages: 276 - 284
Global gene expression profiling and histochemical analysis of the developing human fetal pancreas S. A. SarkarS. KobberupJ. C. Hutton Article 18 December 2007 Pages: 285 - 297
Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation A. FornoniA. PileggiR. L. Pastori Article 08 December 2007 Pages: 298 - 308
Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients I. M. JazetG. SchaartA. E. Meinders Article 14 December 2007 Pages: 309 - 319
Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men J. W. E. JockenG. H. GoossensE. E. Blaak Article Open access 05 December 2007 Pages: 320 - 327
Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance P. SjögrenJ. Sierra-JohnsonR. M. Fisher Article 20 November 2007 Pages: 328 - 335
Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle M. S. RadinS. SinhaR. M. O’Doherty Article 01 December 2007 Pages: 336 - 346
Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study A. JeandrotJ.-L. RichardJ.-P. Lavigne Article 13 October 2007 Pages: 347 - 352
Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type 1 diabetes V. L. FranklinF. KhanS. A. Greene Article 27 November 2007 Pages: 353 - 360
Retinal haemodynamics in individuals with well-controlled type 1 diabetes M. LorenziG. T. FekeJ. W. McMeel Short Communication Open access 20 November 2007 Pages: 361 - 364
Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes E. S. KilpatrickA. S. RigbyS. L. Atkin Article 27 November 2007 Pages: 365 - 371
Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy T. J. M. WijnhovenM. J. W. van den HovenX. Xu Article 06 December 2007 Pages: 372 - 382
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes T. SparsøG. AndersenO. Pedersen Erratum 07 December 2007 Pages: 383 - 383
